6826 — Shanghai Haohai Biological Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$5.11bn
- HK$2.90bn
- CNY2.47bn
Annual cashflow statement for Shanghai Haohai Biological Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -926 | -1,166 | -1,384 | -1,378 | -1,403 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 342 | 231 | 634 | 649 | 491 |
| Capital Expenditures | -272 | -317 | -267 | -363 | -187 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 124 | -365 | -109 | 646 | 387 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -148 | -682 | -377 | 282 | 201 |
| Financing Cash Flow Items | -82.8 | -179 | -555 | -208 | -284 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -231 | -288 | -258 | -390 | -581 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -44 | -725 | 10.1 | 544 | 115 |